BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19502078)

  • 21. Comparison of oncogene mutation detection and telomerase activity for the molecular staging of non-small cell lung cancer.
    Ahrendt SA; Yang SC; Wu L; Westra WH; Jen J; Califano JA; Sidransky D
    Clin Cancer Res; 1997 Jul; 3(7):1207-14. PubMed ID: 9815801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telomerase activity in transthoracic fine needle biopsy aspirates as a marker of peripheral lung cancer.
    Targowski T; Jahnz-Rózyk K; Szkoda T; From S; Qandil N; Plusa T
    Thorax; 2008 Apr; 63(4):342-4. PubMed ID: 18057096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of circulating carcinoma cells by telomerase activity.
    Gauthier LR; Granotier C; Soria JC; Faivre S; Boige V; Raymond E; Boussin FD
    Br J Cancer; 2001 Mar; 84(5):631-5. PubMed ID: 11237383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of mutant p53 and telomerase activity in non-small cell lung cancer.
    Kiyooka K; Maniwa Y; Okada M
    Ann Thorac Cardiovasc Surg; 1999 Oct; 5(5):293-9. PubMed ID: 10550714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control.
    Hsu IL; Su WC; Yan JJ; Chang JM; Lai WW
    Lung Cancer; 2009 Sep; 65(3):371-6. PubMed ID: 19157636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should three slide-touch print cytology replace pleural lavage cytology for detection of pleural micrometastases in cases of bronchogenic carcinoma?
    Alayouty HD; Amin MM; Aloukda AW; Bafakeer SS; Sulieman DD
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):728-32. PubMed ID: 21343156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of telomeric repeat length alterations in pathological stage I-IIIA non-small cell lung cancer.
    Hirashima T; Komiya T; Nitta T; Takada Y; Kobayashi M; Masuda N; Matui K; Takada M; Kikui M; Yasumitu T; Ohno A; Nakagawa K; Fukuoka M; Kawase I
    Anticancer Res; 2000; 20(3B):2181-7. PubMed ID: 10928174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of pleural lavage cytology after thoracotomy and before closure of the chest in lung cancer.
    Taniguchi Y; Nakamura H; Miwa K; Adachi Y; Fujioka S; Haruki T; Horie Y
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):102-6. PubMed ID: 19401295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum carcinoembryonic antigen level and pleural lavage cytology in woman with non-small cell lung cancer.
    Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
    Thorac Cardiovasc Surg; 2008 Oct; 56(7):422-5. PubMed ID: 18810701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrence patterns in patients with early stage non-small cell lung cancers undergoing positive pleural lavage cytology.
    Satoh Y; Hoshi R; Ishikawa Y; Horai T; Okumura S; Nakagawa K
    Ann Thorac Surg; 2007 Jan; 83(1):197-202. PubMed ID: 17184661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrence pattern and rapid intraoperative detection of carcinoembryonic antigen (CEA) mRNA in pleural lavage in patients with non-small cell lung cancer (NSCLC).
    Sugai S; Satoh Y; Komatsu M; Okumura S; Nakagawa K; Ishikawa Y; Miki Y
    Rinsho Byori; 2008 Oct; 56(10):851-7. PubMed ID: 19068780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telomerase activity and serum levels of p53 protein as prognostic factors of survival in patients with advanced non-small cell lung cancer.
    Targowski T; Jahnz-Rozyk K; Owczarek W; Raczka A; Janda P; Szkoda T; Płusa T
    Respir Med; 2010 Sep; 104(9):1356-61. PubMed ID: 20363608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.
    Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M
    J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of pleural lavage cytology examined during surgery for primary lung cancer.
    Kaneda M; Yokoi K; Ito S; Niwa H; Takao M; Kondo R; Arimura T; Saito Y
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):1335-41. PubMed ID: 22223692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
    Werle B; Lötterle H; Schanzenbächer U; Lah TT; Kalman E; Kayser K; Bülzebruck H; Schirren J; Krasovec M; Kos J; Spiess E
    Br J Cancer; 1999 Oct; 81(3):510-9. PubMed ID: 10507778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of positive pleural lavage cytology on survival in patients having lung resection for non-small-cell lung cancer: An international individual patient data meta-analysis.
    Lim E; Clough R; Goldstraw P; Edmonds L; Aokage K; Yoshida J; Nagai K; Shintani Y; Ohta M; Okumura M; Iwasaki T; Yasumitsu T; Okada M; Mimura T; Tsubota N; Nakagawa T; Okumura N; Satoh Y; Okumura S; Nakagawa K; Higashiyama M; Kodama K; Riquet M; Vicidomini G; Santini M; Kotoulas C; Hsu JY; Chen CY;
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1441-6. PubMed ID: 19939412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of pleural effusion in patients with non-small cell lung cancer.
    Sugiura S; Ando Y; Minami H; Ando M; Sakai S; Shimokata K
    Clin Cancer Res; 1997 Jan; 3(1):47-50. PubMed ID: 9815536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination.
    Lee WY
    Cytopathology; 2005 Oct; 16(5):227-32. PubMed ID: 16181308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma.
    Fujita Y; Fujikane T; Fujiuchi S; Nishigaki Y; Yamazaki Y; Nagase A; Shimizu T; Ohsaki Y; Kikuchi K
    Cancer; 2003 Sep; 98(5):1008-13. PubMed ID: 12942569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.